These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 26980741)

  • 1. Factors associated with thrombosis in pediatric patients with systemic lupus erythematosus.
    Driest KD; Sturm MS; O'Brien SH; Spencer CH; Stanek JR; Ardoin SP;
    Lupus; 2016 Jun; 25(7):749-53. PubMed ID: 26980741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superficial vein thrombosis, thrombin generation and activated protein C resistance as predictors of thromboembolic events in lupus and antiphospholipid patients. A prospective cohort study.
    Zuily S; Regnault V; Guillemin F; Kaminsky P; Rat AC; Lecompte T; Wahl D
    Thromb Res; 2013 Jul; 132(1):e1-7. PubMed ID: 23676348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying additional risk factors for arterial and venous thrombosis among pediatric antiphospholipid antibodies carriers.
    Sloan E; Wright T; Zuo Y
    Lupus; 2021 Apr; 30(5):828-832. PubMed ID: 33736541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients.
    Tarr T; Lakos G; Bhattoa HP; Shoenfeld Y; Szegedi G; Kiss E
    Lupus; 2007; 16(1):39-45. PubMed ID: 17283584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Avascular necrosis of bone and antiphospholipid antibodies in systemic lupus erythematosus.
    Asherson RA; Lioté F; Page B; Meyer O; Buchanan N; Khamashta MA; Jungers P; Hughes GR
    J Rheumatol; 1993 Feb; 20(2):284-8. PubMed ID: 8474066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies.
    Horbach DA; van Oort E; Donders RC; Derksen RH; de Groot PG
    Thromb Haemost; 1996 Dec; 76(6):916-24. PubMed ID: 8972011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiphospholipid antibodies in pediatric systemic lupus erythematosus.
    Seaman DE; Londino AV; Kwoh CK; Medsger TA; Manzi S
    Pediatrics; 1995 Dec; 96(6):1040-5. PubMed ID: 7491218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiphospholipid antibodies in pediatric systemic lupus erythematosus and the antiphospholipid syndrome.
    Avcin T; Silverman ED
    Lupus; 2007; 16(8):627-33. PubMed ID: 17711899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homocysteine, antiphospholipid antibodies and risk of thrombosis in patients with systemic lupus erythematosus.
    Martínez-Berriotxoa A; Ruiz-Irastorza G; Egurbide MV; Rueda M; Aguirre C
    Lupus; 2004; 13(12):927-33. PubMed ID: 15645748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies.
    Tektonidou MG; Laskari K; Panagiotakos DB; Moutsopoulos HM
    Arthritis Rheum; 2009 Jan; 61(1):29-36. PubMed ID: 19116963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
    Alpert D; Mandl LA; Erkan D; Yin W; Peerschke EI; Salmon JE
    Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship of antiphospholipid antibodies to thromboembolic events in pediatric patients with systemic lupus erythematosus: a cross-sectional study.
    Berube C; Mitchell L; Silverman E; David M; Saint Cyr C; Laxer R; Adams M; Vegh P; Andrew M
    Pediatr Res; 1998 Sep; 44(3):351-6. PubMed ID: 9727712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Risk factors for the development of thrombotic complication in patients with lupus erythematosus and lupus nephropatic].
    Zaldívar-Alcántara H; Herrera-Jiménez LE; Dehesa-López E; Correa-Rotter R
    Rev Invest Clin; 2013; 65(3):199-208. PubMed ID: 23877806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of antiphospholipid antibody levels and type on thrombotic manifestations: results from the Serbian National Cohort Study.
    Stojanovich L; Markovic O; Marisavljevic D; Elezovic I; Ilijevski N; Stanisavljevic N
    Lupus; 2012 Mar; 21(3):338-45. PubMed ID: 21993381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor V Leiden, antiphospholipid antibodies and thrombosis in systemic lupus erythematosus.
    Fijnheer R; Horbach DA; Donders RC; Vilé H; von Oort E; Nieuwenhuis HK; Gmelig-Meijling FH; de Groot PG; Derksen RH
    Thromb Haemost; 1996 Oct; 76(4):514-7. PubMed ID: 8902988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
    Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
    J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent antiphospholipid antibody (aPL) in asymptomatic carriers as a risk factor for future thrombotic events: a nationwide prospective study.
    Mustonen P; Lehtonen KV; Javela K; Puurunen M
    Lupus; 2014 Dec; 23(14):1468-76. PubMed ID: 25164304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erythematosus.
    Martinez-Berriotxoa A; Ruiz-Irastorza G; Egurbide MV; Garmendia M; Gabriel Erdozain J; Villar I; Aguirre C
    Lupus; 2007; 16(10):810-6. PubMed ID: 17895304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical significance of antiphospholipid antibody in pediatric patients and review of literature].
    Xiao HJ; Yang JY; Gao TJ; Huang JP; Yao Y; Zhang Y
    Zhonghua Er Ke Za Zhi; 2004 Aug; 42(8):571-3. PubMed ID: 15347440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.